5-alpha-reductase deficiency secondary prevention

Jump to navigation Jump to search

5-alpha-reductase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 5-alpha-reductase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

Pelvic X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

5-alpha-reductase deficiency secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 5-alpha-reductase deficiency secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 5-alpha-reductase deficiency secondary prevention

CDC on 5-alpha-reductase deficiency secondary prevention

5-alpha-reductase deficiency secondary prevention in the news

Blogs on 5-alpha-reductase deficiency secondary prevention

Directions to Hospitals Treating 5-alpha-reductase deficiency

Risk calculators and risk factors for 5-alpha-reductase deficiency secondary prevention

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS